The P.I. of the project was a member of the Program Organizing Committee of the 3rd Congress on Steroid Research, which took place between November 15 and 18, 2015 in Chicago USA (http://www.steroidresearchcongress.com/conference-committee.html). Currently she is a member of the Program Organizing Committee of the 4th Congress on Steroid Research, which will take place between July 8-11, 2018 in Seoul, South Korea (http://csr2018.org/index.php?hCode=ORGANIZATION_02_01).
D.03 Membership in foreign/international boards/committees
Since 2015 P.I. of the project is an Associate Editor of the Journal of Steroid Biochemistry and Molecular Biology, (I.F. = 4,561). (http://www.journals.elsevier.com/the-journal-of-steroid-biochemistry-and-molecular-biology/editorial-board/)
C.04 Editorial board of an international magazine
P.I. of the project was an invited speaker at the 2nd Austrian Biomarker Symposium: Early Diagnostics, Vienna, Austria in 2014 and at the Workshop on Targeted Metabolomics, Neuherberg, Germany in 2015. She presented the results on metabolomics study in patients with ovarian endometriosis and diagnostic model containing hydroxysphingomyelin SMOH C16:1 and the ratio between phosphatidylcholine PCaa C36:2 to ether-phospholipid PCae C34:2, adjusted for the effect of age and the BMI, with a great diagnostic characteristics, sensitivity of 90.0%, a specificity of 84.3% .
B.04 Guest lecture
COBISS.SI-ID: 32382937At 3rd European Congress on Endometriosis, which took place in Budapest, between 17th and 19th November 2016 the PI of the project presented a study on tumor markers CA-125 and HE4 in patients with endometriosis. Diagnostic model with good characteristics which included concentration of CA-125, together with information on pain and presence of cysts.
B.03 Paper at an international scientific conference
COBISS.SI-ID: 32963801The PI of the project wrote Editorial for the Journal of Steroid Biochemistry and Molecular Biology as guidelines for description and validation of antibodies used in research. Antibodies have key roles in the number of experimental methods such as Western blotting, immunohistochemistry, ELISA and antibody arrays, among others. Researchers are often not aware that commercially available antibodies have not been appropriately validated and may not be specific. This Editorial aims to increase the knowledge on appropriate validation and use of antibodies in research and thus to contribute to a better reproducibility and better quality of published studies.
C.07 Other editorial board
COBISS.SI-ID: 32355801